View More Recent Stories

Mar 11, 2025 08:00AM An Interview with the CEO: How Aspire Biopharma is Disrupting a $100 Billion Market with Sublingual Innovation

Mar 3, 2025 07:30AM Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement

Feb 25, 2025 07:33AM Aspire Biopharma Holdings (ASBP) Provides an Update on Lead Product Candidate

Feb 25, 2025 07:30AM Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin

Feb 20, 2025 06:15PM Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement

View More Recent Stories